151 related articles for article (PubMed ID: 33889258)
1. [Malignant mesothelioma of the ovary: a case report].
Ouafki I; Nouiakh L; Boujarnija R; Amarti A; Amaadour L; Oualla K; Benbrahim Z; Arifi S; Mellas N
Pan Afr Med J; 2021; 38():92. PubMed ID: 33889258
[TBL] [Abstract][Full Text] [Related]
2. Ovarian metastasis from malignant pleural mesothelioma.
Naldi G; Bergomi S; Visca P; Cecere FL
Tumori; 2020 Dec; 106(6):NP49-NP51. PubMed ID: 32684102
[TBL] [Abstract][Full Text] [Related]
3. Use of computed tomography and positron emission tomography/computed tomography for staging of local extent in patients with malignant pleural mesothelioma.
Frauenfelder T; Kestenholz P; Hunziker R; Nguyen TD; Fries M; Veit-Haibach P; Husmann L; Stahel R; Weder W; Opitz I
J Comput Assist Tomogr; 2015; 39(2):160-5. PubMed ID: 25354093
[TBL] [Abstract][Full Text] [Related]
4. Clinically occult primary fallopian tube carcinoma presenting as a malignant pleural effusion.
Hiensch R; Meinhof K; Leytin A; Hagopian G; Szemraj E; Epelbaum O
Clin Respir J; 2017 Nov; 11(6):1086-1090. PubMed ID: 26646473
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Imaging and workup of Malignant Pleural Mesothelioma.
Cardinale L; Ardissone F; Gned D; Sverzellati N; Piacibello E; Veltri A
Acta Biomed; 2017 Aug; 88(2):134-142. PubMed ID: 28845826
[TBL] [Abstract][Full Text] [Related]
6. Imaging of mesothelioma.
Gill RR
Recent Results Cancer Res; 2011; 189():27-43. PubMed ID: 21479894
[TBL] [Abstract][Full Text] [Related]
7. Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.
van Zandwijk N; Pavlakis N; Kao SC; Linton A; Boyer MJ; Clarke S; Huynh Y; Chrzanowska A; Fulham MJ; Bailey DL; Cooper WA; Kritharides L; Ridley L; Pattison ST; MacDiarmid J; Brahmbhatt H; Reid G
Lancet Oncol; 2017 Oct; 18(10):1386-1396. PubMed ID: 28870611
[TBL] [Abstract][Full Text] [Related]
8. Sarcomatoid Type of Paratesticular Malignant Mesothelioma in a Dry-Cleaning Worker Exposed to Asbestos and Diagnostic Value of WT-1.
Kilitci A; Uygun N; Emir ML
P R Health Sci J; 2020 Mar; 39(1):39-44. PubMed ID: 32383566
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of metabolic response by positron emission tomography after neoadjuvant chemotherapy for resectable malignant pleural mesothelioma.
Tsutani Y; Takuwa T; Miyata Y; Fukuoka K; Hasegawa S; Nakano T; Okada M
Ann Oncol; 2013 Apr; 24(4):1005-10. PubMed ID: 23136224
[TBL] [Abstract][Full Text] [Related]
10. Integrated positron emission tomography-computed tomography does not accurately stage intrathoracic disease of patients undergoing trimodality therapy for malignant pleural mesothelioma.
Pilling J; Dartnell JA; Lang-Lazdunski L
Thorac Cardiovasc Surg; 2010 Jun; 58(4):215-9. PubMed ID: 20514576
[TBL] [Abstract][Full Text] [Related]
11. Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
Kircheva DY; Husain AN; Watson S; Kindler HL; Durkin A; Vigneswaran WT
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1642-7. PubMed ID: 26802143
[TBL] [Abstract][Full Text] [Related]
12. Complete response and long-term survival in malignant pleural mesothelioma: case report.
Takanen S; Resuli B; Graziano V; Parisi A; Lisi R; Raffetto N; Tombolini V
Anticancer Res; 2012 Apr; 32(4):1485-7. PubMed ID: 22493390
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic laparoscopy identifies a peritoneal adenomatoid-like mesothelioma masquerading as ovarian cancer: a case report.
Okuda T; Ogino Y; Yamashita S; Ishii H; Kin S; Nagata A; Otsubo M; Kataoka H; Kitawaki J
Eur J Gynaecol Oncol; 2014; 35(1):91-4. PubMed ID: 24654472
[TBL] [Abstract][Full Text] [Related]
14. Ovarian cancer.
Mironov S; Akin O; Pandit-Taskar N; Hann LE
Radiol Clin North Am; 2007 Jan; 45(1):149-66. PubMed ID: 17157627
[TBL] [Abstract][Full Text] [Related]
15. Does positron emission tomography offer prognostic information in malignant pleural mesothelioma?
Sharif S; Zahid I; Routledge T; Scarci M
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):806-11. PubMed ID: 21266493
[TBL] [Abstract][Full Text] [Related]
16. The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis.
Klebe S; Nakatani Y; Dobra K; Butnor KJ; Roden AC; Nicholson AG; Marchevsky AM; Husain AN; Segal A; Walts AE; Weynand B; Michael CW; Dacic S; Godbolt D; Attanoos R; Santoni-Rugiu E; Galateau-Salle F; Hiroshima K; Moreira AL; Burn J; Nabeshima K; Gibbs AR; Churg A; Litzky LA; Brcic L; Tsao MS; Mino-Kenudson M; Rørvig SB; Tazelaar HD; Krausz T; Zhang YZ; Chirieac LR; Beasley MB; Hjerpe A
Pathology; 2021 Jun; 53(4):446-453. PubMed ID: 33775406
[TBL] [Abstract][Full Text] [Related]
17. Malignant mesothelioma associated with localized myocardial fibrosis: a case report.
Vymetalova K; Tomasov P; Polasek R
BMC Cardiovasc Disord; 2021 Jun; 21(1):282. PubMed ID: 34098884
[TBL] [Abstract][Full Text] [Related]
18. Stage III disease of ovarian, tubal and peritoneal cancers can be accurately diagnosed with pre-operative CT. Japan Clinical Oncology Group Study JCOG0602.
Onda T; Tanaka YO; Kitai S; Manabe T; Ishikawa M; Hasumi Y; Miyamoto K; Ogawa G; Satoh T; Saito T; Kasamatsu T; Nakanishi T;
Jpn J Clin Oncol; 2021 Feb; 51(2):205-212. PubMed ID: 33556170
[TBL] [Abstract][Full Text] [Related]
19. A case of localized peritoneal malignant mesothelioma with ovarian metastasis and literature review.
Wang J; Hu R; He Q
Med Lav; 2022 Aug; 113(4):e2022035. PubMed ID: 36006096
[TBL] [Abstract][Full Text] [Related]
20. First-line chemotherapy with pemetrexed plus cisplatin for malignant peritoneal mesothelioma.
Fujimoto E; Kijima T; Kuribayashi K; Negi Y; Kanemura S; Mikami K; Doi H; Kitajima K; Nakano T
Expert Rev Anticancer Ther; 2017 Sep; 17(9):865-872. PubMed ID: 28594258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
